Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Space technologies
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 2879/19 19-11-2021
Facebook X Linkedin Email

T 2879/19 19-11-2021

European Case Law Identifier
ECLI:EP:BA:2021:T287919.20211119
Date of decision
19 November 2021
Case number
T 2879/19
Petition for review of
-
Application number
13769011.1
IPC class
A01N 47/36
A01N 41/10
A01N 43/10
A01N 43/40
A01N 43/70
A01N 43/80
A01N 43/824
A01P 13/00
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 407.71 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

HERBICIDAL COMPOSITION

Applicant name
Ishihara Sangyo Kaisha, Ltd.
Opponent name
-
Board
3.3.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
European Patent Convention Art 84
European Patent Convention Art 123(2)
Keywords

Claims

Inventive step

Amendments

Catchword
-
Cited decisions
G 0010/93
T 0025/09
T 1253/11
Citing decisions
-

I. The appeal by the applicant ("appellant") lies from the decision of the examining division to refuse European patent application No. 13 769 011.1 on the basis of the main request.

II. Claim 1 of the main request reads as follows:

"1. A herbicidal composition comprising, as active ingredients, (a) nicosulfuron or its salt, (b) terbuthylazine or its salt and (c) compound C (compound C is at least one herbicidal compound selected from the group consisting of group C1 and group C2 or its salt; Group C1 is at least one 4-hydroxyphenylpyruvate dioxygenase inhibitor selected from the group consisting of sulcotrione, mesotrione, and their salts; and group C2 is at least one very long chain fatty acid biosynthesis inhibitor selected from the group consisting of dimethenamid-P, flufenacet and their salts)."

III. The following documents are referred to in the present decision:

D1 |EP 0 614 606 A2 |

D2 |WO 02/100173 A1 |

D3 |CN 101 965 846 |

D5 |JP 2007 291055 A |

Attachment-1|Experimental report filed on 24 May 2016|

Annex-1 |Additional experimental data filed with the statement of grounds of appeal |

IV. The examining division came to the conclusion that the subject-matter of claims 1 to 12 according to the main request did not involve an inventive step in view of either D2 or D5 as the closest prior art in combination with either D1 or D3.

V. In its statement setting out the grounds of appeal, the appellant contested the examining division's decision. It submitted claim sets of a main request and auxiliary requests 1 to 10 and argued that the subject-matter of the claims of the main request involved an inventive step. The claim set of the main request corresponded to the claim set of the main request submitted before the examining division.

VI. On 27 August 2021, the appellant was summoned to attend oral proceedings on 19 November 2021.

VII. With a letter of 31 August 2021, the appellant requested postponement of the oral proceedings.

VIII. In a communication dated 8 September 2021, the board informed the appellant that it could not accede to the appellant's request for postponement of the oral proceedings.

IX. On 15 September 2021, the board issued a communication in preparation for the oral proceedings, which had been arranged as requested by the appellant. Objections under Articles 56 and 84 EPC were raised against the claims of the main request.

X. With a further letter dated 15 October 2021, the appellant filed a main request* and auxiliary requests 1* to 8*. It submitted arguments against the objections under Articles 56 and 84 EPC.

XI. Oral proceedings before the board were held on 19 November 2021 by videoconference.

XII. Appellant 1's arguments, where relevant to the present decision, may be summarised as follows.

Main request and auxiliary requests 1 to 8 - Clarity of the claims

- The skilled person could understand the claimed subject-matter, based on the disclosure provided in the description.

- The objections of lack of clarity had not been raised by the examining division.

Main request*, auxiliary requests 1* to 8* and auxiliary requests 9 and 10 - Inventive step

- D5 disclosed a synergistic composition comprising nicosulfuron and terbuthylazine. Considering D5 as the closest prior art, the distinguishing feature of claim 1 of any of these requests was the presence of mesotrione.

- The compositions according to claim 1 of any of these requests were more efficient than the composition according to D5, even more efficient than expected.

- The objective technical problem was the provision of a herbicidal composition exhibiting synergism.

- A mixture comprising nicosulfuron and mesotrione exhibited antagonism, as shown in table A of annex-1. Therefore, it would not have been obvious that a ternary mixture comprising nicosulfuron, terbuthylazine and mesotrione as claimed would have a synergistic effect.

- Furthermore, the solution proposed by claim 1 of any of auxiliary requests 1* to 8* and auxiliary requests 9 and 10 was not obvious in view of D2 since D2 did not disclose synergistic compositions in an enabling manner.

- Therefore, the subject-matter of claim 1 of any of auxiliary requests 1* to 8* and auxiliary requests 9 and 10 involved an inventive step.

Auxiliary request 11 - Inventive step

- When considering D5 as the closest prior art, the distinguishing feature of claim 1 of auxiliary request 11 was sulcotrione and its salt.

- Table 1-1 of attachment-1 showed that compositions according to claim 1 of auxiliary request 11 were more efficient than expected when compared to the composition of D5.

- The objective technical problem was the provision of a method for controlling undesired plants or inhibiting their growth, this method exhibiting synergism.

- There was no teaching in D1, D2 or D3 that the addition of sulcotrione and its salt would provide further synergism to a composition comprising compounds A and B.

XIII. The appellant requested that the decision under appeal be set aside and that the application be granted on the basis of the claim set of the main request or alternatively on the basis of the claim set of any of the main request* and auxiliary requests 1, 1*, 2, 2*, 3, 3*, 4, 4*, 5, 5*, 6, 6*, 7, 7*, 8, 8*, 9, 10 and 11. The claim requests without asterisk were filed with the statement of grounds of appeal, and the claim requests with an asterisk were filed by letter dated 15 October 2021. Auxiliary request 11 was filed during the oral proceedings before the board.

Main request - Claims 1 to 12 filed on 24 May 2016

1. Article 84 EPC

1.1 Claims 1 and 7 comprise the following bracketed expression:

"(compound C is at least one herbicidal compound selected from the group consisting of group C1 and group C2 or its salt; Group C1 is at least one 4-hydroxyphenylpyruvate dioxygenase inhibitor selected from the group consisting of sulcotrione, mesotrione and their salts; and group C2 is at least one very long chain fatty acid biosynthesis inhibitor selected from the group consisting of dimethenamid-P, flufenacet and their salts)"

The bracketed expression is not a reference sign in claims 1 and 7. It is therefore not clear whether the bracketed expression is an optional or mandatory feature of claim 1 or 7. It follows that compound C in claims 1 and 7 of the main request is not clearly defined, and thus the claims lack clarity.

1.2 Claim 10 reads as follows: "The method according to Claim 7, wherein the undesired plants are weeds having lowered sensitivity to herbicidal compounds."

The term "lowered sensitivity" lacks clarity since claim 10 has neither a standard for comparing the sensitivity nor information for establishing whether the sensitivity is lowered. Thus, the skilled person cannot clearly determine the weeds falling under the definition of the claim. Therefore, the claim lacks clarity.

1.3 Claims 2, 11 and 12 refer to mixing ratios defined by the expression "by the weight ratio". However, the expression "mixing ratio ... by the weight ratio" is not recognised in the art. The skilled person is thus in doubt concerning the meaning of this expression. Claims 2, 11 and 12 therefore lack clarity.

1.4 Claim 12 reads as follows: "12. The herbicidal composition according to Claim 11, wherein the mixing ratio of (a) to (c) sulcotrione or its salt is from 1:0.5 to 1:200 by the weight ratio, the mixing ratio of (a) to (c) mesotrione or its salt is from 1:0.25 to 1:12 by the weight ratio, the mixing ratio of (a) to (c) dimethenamid-P or its salt is from 1:2 to 1:200 by the weight ratio, and the mixing ratio of (a) to (c) flufenacet or its salt is from 1:3 to 1:30 by the weight ratio."

It is not clear whether the mentioning of four mixing ratios in claim 12 for four different components (c) implies that component (c) is a mixture of all four components, i.e. sulcotrione, mesotrione, dimethenamid-P and flufenacet, or whether component (c) according to claim 12 may contain only one of these four components. Thus, claim 12 lacks clarity.

1.5 The appellant argued that, based on the disclosure provided in the description, the claims were clear for the skilled person.

The board does not agree. The claims must be clear in themselves when read by the person skilled in the art, without any reference to the content of the description (see e.g. T 1253/11, Reasons 2.2.2). Thus, the appellant's argument must fail.

1.6 The appellant submitted during oral proceedings that the objections of lack of clarity had not been raised by the examining division.

It is indeed true that these objections were raised for the first time by the board. However, following the principles set out in G 10/93, OJ EPO, 1995, 172 (Reasons 3 and 4), the board has the power to examine whether the application or the invention to which it relates meets the requirements of the EPC, including requirements which the examining division did not take into consideration. The fact that the examining division's decision is silent on the requirements of Article 84 EPC does not prevent the board from assessing the clarity of claims.

1.7 In view of the above, the board concludes that claims 1, 2, 7, 10, 11 and 12 do not meet the requirements of Article 84 EPC.

2. It follows that the main request is not allowable.

Auxiliary requests 1 to 8 (filed with the statement of grounds of appeal)

3. Auxiliary requests 1 to 8 comprise claim(s) having at least one of the same deficiencies as claims 1, 2, 7, 10, 11 and 12 of the main request. This was not disputed by the appellant.

Thus, auxiliary requests 1 to 8 are not allowable.

Main request* and auxiliary requests 1* and 2* (filed with the letter of 15 October 2021)

4. Article 56 EPC

Claim 1 of auxiliary request 2* relates to a herbicidal composition comprising:

(a) nicosulfuron or its salt

(b) terbuthylazine or its salt

(c) at least one of sulcotrione, mesotrione, dimethenamid-P, flufenacet and their salts

The above commercial names represent well-defined herbicides.

In the following, nicosulfuron and terbuthylazine are called compound A and compound B, and the compound defined under (c) above is called compound C.

Claim 1 of auxiliary request 2* also defines the undesired plants. These undesired plants are at least one member selected from the group consisting of malvaceae, compositae, chenopodiaceae and solanaceae.

The aim of the invention is to provide a high active herbicidal composition having a broader herbicidal spectrum (page 2, lines 7 to 8 of the description). The compositions according to the application exhibit a synergistic effect (e.g. page 4, lines 4 to 5 and 10 to 12).

4.1 Closest prior art D5

D5 relates to a synergistic herbicidal composition comprising nicosulfuron (corresponding to compound A of claim 1) and terbuthylazine (corresponding to compound B of claim 1) (paragraph [0005] of the translation). The composition is reported to exhibit a synergistic herbicidal effect (paragraph [0006] of the translation). Furthermore, D5 discloses a list of undesired plants (sixth full paragraph on page 2), among which ragweed is mentioned. This plant belongs to the genus Ambrosia spp., which itself belongs to the family Compositae (see the application on page 9, lines 1 to 9), corresponding to the undesired plants of claim 1.

4.2 Distinguishing feature

The distinguishing feature of claim 1 of auxiliary request 2* in view of D5 is compound C, i.e. at least one of sulcotrione, mesotrione, dimethenamid-P, flufenacet and their salts.

4.3 Technical effect and objective technical problem

In the data of attachment-1 and annex-1, the following is shown.

Table 1-1 of attachment-1 shows the growth inhibition rates for velvetleaf (malvaceae) when using (i) a composition comprising compound A, compound B and sulcotrione as compound C, i.e. a composition as claimed, and (ii) a composition comprising compounds A and B, i.e. a composition as disclosed in D5. The table shows visually observed growth inhibition rates (column X) and calculated values of growth inhibition rates (column Y).

The expected growth inhibition rate of a composition (A+B)+C, according to claim 1 of auxiliary request 2*, is 87 or 89% under no rainfall conditions (row "(A+B)+C", column Y, "no rainfall" of table 1-1). The visually observed growth inhibition for the mixture A+B+C is 95 or 98% under the same conditions (row "A+B+C", column X, "no rainfall" of table 1-1).

The expected growth inhibition rate of a composition (A+B)+C, according to claim 1 of auxiliary request 2*, ranges from 64 to 72% under rainfall conditions (row "(A+B)+C", column Y, "rainfall" of table 1-1). The visually observed growth inhibition for the mixture A+B+C ranges from 87 to 94% under the same conditions (row "A+B+C", column X, "rainfall" of table 1-1).

The observed velvetleaf growth inhibition rates for a composition according to D5 ("A+B") are 35% under no rainfall conditions (row "(A+B)", column X, "no rainfall" of table 1-1), and 25 and 10% under rainfall conditions (row "(A+B)", column X, "rainfall").

Table 1-1 of attachment-1 thus shows that compositions "A+B+C" (C being sulcotrione), i.e. compositions according to claim 1 of auxiliary request 2*, are more efficient than expected when compared to compositions "A+B" according to D5.

Similar conclusions can be made when considering the velvetleaf growth inhibition rates shown in table 1-2 of attachment-1 with compound C being mesotrione, table 1-3 of attachment-1 with compound C being flufenacet and table C of annex-1 with compound C being dimethenamid-P.

Tables 1-1 to 1-3 of attachment-1 and table C of annex-1 thus show that compositions "A+B+C", according to claim 1 of auxiliary request 2*, are more efficient than expected when compared to compositions "A+B" according to D5.

The fact that the inhibition rates observed for compositions "A+B+C" are more efficient than expected implies that compound C acts synergistically with the synergistic composition A+B disclosed in D5.

Based on the above considerations, the objective technical problem may be formulated as (different from the examining division's formulation of an alternative herbicide), the provision of a herbicidal composition exhibiting further synergism over that of D5.

4.4 Obviousness

The solution proposed by claim 1 of auxiliary request 2* is obvious in view of D2 and D3.

D2 relates to a synergistic herbicidal composition comprising mesotrione (compound C of claim 1) and a second herbicide (claim 1 of D2). The second herbicide may be terbuthylazine (claim 2 of D2) (compound B of claim 1). Thus, D2 discloses a synergistic herbicidal composition comprising compound B and a compound C (mesotrione). The skilled person would have investigated replacing compound B in the composition disclosed in D5 with a synergistic mixture of B+C as disclosed in D2 when seeking further synergism since they would have expected that the synergism between B and C as taught by D2 would add to that between A and B observed in D5. Hence, the skilled person would have arrived at the subject-matter of claim 1 of auxiliary request 2* without inventive merit.

The same conclusion applies for D3. D3 (abstract) discloses a synergistic herbicidal composition comprising nicosulfuron (compound A) and flufenacet (a compound C). The skilled person would have investigated replacing compound A in the composition of D5 with the synergistic mixture of A+C as disclosed in D3 when seeking further synergism.

4.5 The appellant submitted that a mixture A+C, when C is mesotrione, exhibited antagonism, as shown in table A of annex-1. Therefore, it would not have been obvious that a corresponding ternary mixture A+B+C would have had a synergistic effect since the skilled person would not have known how the antagonism effect of A+C would have affected a ternary composition A+B+C.

The board does not agree.

The cited prior art does not teach any antagonism that would have prevented the skilled person from adding compound C in the composition A+B of D5. In the absence of a prejudice demonstrated by reference to the literature or encyclopaedias published before the priority date (see e.g. T 25/09, Reasons 17), the appellant's argument is not accepted.

4.6 The appellant further submitted that D2 did not disclose synergistic compositions in an enabling manner. D2 did not contain any examples showing any synergism between terbuthylazine and mesotrione (respectively compounds B and C according to claim 1 of auxiliary request 2*). Only during the examination phase did the applicant of D2 file some evidence of a synergistic effect for a composition comprising mesotrione and a compound different from terbuthylazine.

4.6.1 The board cannot accept the appellant's argument. The board is of the view that the skilled person looking for a solution to the technical problem posed would have considered the general teaching of a document. When searching for a solution for achieving an effect, they would not have disregarded a document for the sole reason that it comprises no examples evidencing the effect. The skilled person would have considered any document comprising a teaching on how to solve the technical problem. To establish a non-enabling disclosure in a document, it has to be shown that the skilled person would not be in a position to repeat the invention disclosed in that document, considering the common general knowledge. In the case at hand, the appellant did not provide evidence that the skilled person, considering their common general knowledge, could not recognise any synergistic effect in a composition comprising mesotrione and terbuthylazine as disclosed in D2.

The board is also of the view that the skilled person would not have investigated the file history of a patent application - in the current case, the later filing of experimental evidence referred to by the appellant - to establish the technical content of a document. As set out above, a skilled person would have considered only the general teaching of a document.

Thus, the board concludes that there are no apparent reasons to establish that the synergistic compositions of D2 are disclosed in a non-enabling manner.

4.7 For the above reasons, the subject-matter of claim 1 of auxiliary request 2* does not involve an inventive step.

Claim 1 of each of the main request* and auxiliary request 1* corresponds to claim 1 of auxiliary request 2*, except that the composition of claim 1 of the main request* is not limited to any undesired plant and, in claim 1 of auxiliary request 1*, the group of undesired plants is broader than the group of claim 1 of auxiliary request 2*. Thus, the same reasoning applies mutatis mutandis to claim 1 of each of the main request* and auxiliary request 1*.

Auxiliary requests 3* to 8* (filed with the letter of 15 October 2021)

5. Claim 1 of auxiliary request 3* differs from claim 1 of auxiliary request 2* (see 4 above) in that the undesired plants are restricted to the group consisting of Abutilon spp., Ambrosia spp., Chenopodium spp. and Solanum spp.

As set out above (4.1 above), D5 discloses that the synergistic compositions disclosed in the document are used on a wide range of plants, among which ragweed is listed. This plant belongs to the genus Ambrosia, as required by claim 1 of auxiliary request 3*. Thus, claim 1 of auxiliary request 3* does not comprise any further distinguishing feature in comparison to claim 1 of auxiliary request 2*. Therefore, the reasoning given for claim 1 of auxiliary request 2* with regard to inventive step applies to the subject-matter of claim 1 of auxiliary request 3*.

6. Claim 1 of auxiliary request 4* reads as follows:

"1. A herbicidal composition comprising, as active ingredients, (a) nicosulfuron or its salt, (b) terbuthylazine or its salt and (c) compound C, wherein compound C is at least one 4-hydroxyphenylpyruvate dioxygenase inhibitor selected from the group consisting of sulcotrione, mesotrione and their salts."

Claim 1 of auxiliary request 5* differs from claim 1 of auxiliary request 4* in that compound C is restricted to mesotrione.

With regard to claim 1 of auxiliary request 2* (see 4 above), the definition of compound C in claim 1 of auxiliary request 4* and 5* has been restricted to two compounds (sulcotrione and mesotrione) or one compound (mesotrione), respectively. Since D2 discloses a synergistic composition of terbuthylazine and mesotrione (compound C as required by claim 1 of each of auxiliary requests 4* and 5*), the reasoning given for claim 1 of auxiliary request 2* (see 4.2 to 4.4 above) still applies to the subject-matter of claim 1 of each of auxiliary requests 4* and 5*.

7. Claim 1 of auxiliary request 8* relates to a method for controlling undesired plants or inhibiting their growth. This method comprises applying, as active ingredients, compounds A, B and C. Compound C is as defined in claim 1 of auxiliary request 2*, i.e. a compound selected from the group consisting of sulcotrione, mesotrione, dimethenamid-P, flufenacet and their salts. The undesired plants are at least one member selected from the group consisting of Abutilon spp., Ambrosia spp., Chenopodium spp. and Solanum spp., as in claim 1 of auxiliary request 3*.

The closest prior art for the subject-matter of claim 1 of auxiliary request 8* is still document D5.

As set out above (see 4.1), D5 (claim 2) relates to a method for controlling or inhibiting the growth of undesirable plants comprising applying to the plants an effective amount of a composition comprising A and B.

The distinguishing feature of claim 1 of auxiliary request 8* in view of D5 is the presence of compound C in the composition used in the method, i.e. at least one of sulcotrione, mesotrione, dimethenamid-P, flufenacet and their salts.

As set out in the context of claim 1 of auxiliary request 2*, tables 1-1 to 1-3 of attachment-1 and table C of annex-1 show that a method for controlling or inhibiting the growth of undesirable velvetleaf using a compositions "A+B+C", i.e. compositions used in the method of claim 1 of auxiliary request 8*, is more efficient than expected when compared to the method comprising a composition "A+B" according to D5.

Based on the above considerations, the objective technical problem may be formulated as the provision of a method for controlling undesired plants or inhibiting their growth, this method exhibiting further synergism over that of D5.

For the same reasons as those given for claim 1 of auxiliary request 2*, the solution proposed by claim 1 of auxiliary request 8* does not involve an inventive step, D2 and D3 teaching further synergism by replacing compound B with a synergistic mixture of B+C, C being either mesotrione (D2) or flufenacet (D3).

Claim 1 of each of auxiliary requests 6* and 7* corresponds to claim 1 of auxiliary request 8*, except that in the method of claim 1 of auxiliary requests 6* and 7*, the group of undesired plant was broader than the group of claim 1 of auxiliary request 8*. Thus, the same reasoning applies mutatis mutandis to claim 1 of each of auxiliary requests 6* and 7*.

Auxiliary requests 9 and 10 (filed with the statement of grounds of appeal)

8. With regard to claim 1 of auxiliary request 8*, the definition of compound C in claim 1 of auxiliary request 9 or 10 has been restricted to two compounds (sulcotrione and mesotrione) or one compound (mesotrione), respectively.

As set out above, D2 teaches a method using a synergistic composition of B and mesotrione, mesotrione being compound C according to claim 1 of auxiliary request 9 or 10. Thus, the reasoning given for claim 1 of auxiliary request 8* still applies to the subject-matter of claim 1 of each of auxiliary requests 9 and 10.

Auxiliary request 11

9. The set of claims of auxiliary request 11 comprises three claims, claim 1 of which reads as follows:

"1. A method for controlling undesired plants or inhibiting their growth, which comprises applying a herbicidally effective amount of (a) nicosulfuron or its salt, a herbicidally effective amount of (b) terbuthylazine or its salt, and a herbicidally effective amount of (c) sulcotrione and its salt, to the undesired plants or to a place where they grow, wherein the undesired plants are at least one member selected from the group consisting of Abutilon spp., Ambrosia spp., Chenopodium spp. and Solan um spp."

Claim 1 of auxiliary request 11 thus restricts compound C to sulcotrione and its salts.

10. Article 84 EPC

The board is satisfied that claims 1 to 3 of auxiliary request 11 meet the requirements of Article 84 EPC.

The claims of auxiliary request 11 do not comprise any of the unclear terms found in claims 1, 2, 7, 10, 11 and 12 of the main request (see 1.1 to 1.4 above).

11. Article 123(2) EPC

Claim 1 of auxiliary request 11 is based on claim 8 as filed and the passage on page 16, lines 1 to 12. The definition of compound C in claim 8 as filed has been restricted to sulcotrione and its salts, and the list of undesired plants was shrunk to the list comprising Abutilon spp., Ambrosia spp., Chenopodium spp. and Solanum spp.

Claims 2 and 3 of auxiliary request 11 correspond to claims 9 and 10 as filed.

12. Article 56

12.1 As set out above, compound C in claim 1 of auxiliary request 11 is restricted to sulcotrione and its salts.

12.2 Document D5 represents the closest prior art. As set out above, D5 discloses a synergistic composition comprising compounds A and B.

The distinguishing feature of claim 1 of auxiliary request 11 in view of D5 is compound C, i.e. sulcotrione and its salt.

As set out above, table 1-1 of attachment-1 shows that compositions "A+B+C", according to claim 1 of auxiliary request 11, are more efficient than expected when compared to compositions "A+B" according to D5.

Thus, the objective technical problem may be formulated as the provision of a method for controlling undesired plants or inhibiting their growth, this method exhibiting further synergism over that of D5.

None of D1, D2 and D3 teaches that the addition of sulcotrione and its salt would provide further synergism to a composition comprising compounds A and B.

12.3 D2 (see 4.4 above) relates to a synergistic herbicidal composition comprising mesotrione and terbuthylazine (compound B). The subject-matter of claim 1 of auxiliary request 11 differs from D2 in the presence of compounds A and C (sulcotrione). Thus, D2 is less relevant than D5, from which the subject-matter of claim 1 of auxiliary request 11 only differs in the presence of compound C. Consequently, an inventive step can be acknowledged in view of D2 as the closest prior art for the same reasons as those given above for D5.

12.4 Thus, the subject-matter of claim 1 and, by the same token, of claims 2 to 3 of auxiliary request 11 referring back to the method of claim 1, involves an inventive step within the meaning of Article 56 EPC.

13. The board concludes that the claims of auxiliary request 11 meet the requirements of the EPC.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the examining division with the order to grant a patent on the basis of the claims according to auxiliary request 11 filed during the oral proceedings before the board and a description to be adapted thereto.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility